ARAFLOX-LP

Arfalox-LP Ophthalmic Suspension is a combination eye drop formulation that contains Loteprednol Etabonate and Moxifloxacin, designed to treat eye infections with inflammation. Loteprednol Etabonate is a corticosteroid known for its potent anti-inflammatory effects, helping to reduce swelling, redness, and irritation in the eye. It is often used to treat conditions like allergic conjunctivitis, uveitis, or post-surgical inflammation. Moxifloxacin, a broad-spectrum antibiotic from the fluoroquinolone class, effectively combats bacterial eye infections by inhibiting bacterial DNA replication. This combination of an anti-inflammatory corticosteroid and an antibiotic makes Aralox-LP particularly effective for treating bacterial infections that are accompanied by inflammation, such as in bacterial conjunctivitis or after eye surgery. The ophthalmic suspension is formulated to provide targeted delivery to the eye, and it is crucial to follow the prescribed dosage and instructions to avoid potential side effects and ensure optimal outcomes.